BioSpace News Archive

Abivax SA announces its 2021 annual financial results, as of December 31, 2021, and provides an update on the progress of its product pipeline.

New Agreement with Federal Equipment Company Expands Companies Capabilities.

Zymergen Inc. announced it will report preliminary financial results for the fourth quarter and full year 2021 after market close on Tuesday, March 22nd, 2022.

Avid Bioservices, Inc., a dedicated biologics contract development and manufacturing organization working to improve patient lives by providing high quality services to biotechnology and pharmaceutical companies, announced that the company will participate in the KeyBanc Capital Markets Life Sciences & MedTech Forum.

ulrich medical USA, Inc. announced the 2022 faculty and program highlights for the Sixth Cage Madness Spine Education Forum and Bioskills Training to be held in Las Vegas, Nevada on March 19, 2022.

Exagen Inc., a leading provider of autoimmune testing solutions, announced the formation of its new Scientific Advisory Board with appointment of seven doctors and rheumatology experts.

Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company developing therapeutics designed to treat diseases in areas of high unmet need, today reported financial results for the year ended December 31, 2021, and provided a corporate update.

Allied Corp. (“Allied” or the “Company”) (OTCQB: ALID) is pleased to announce that it has successfully filed for a full patent regarding “DOSING REGIMES OF PHARMACEUTICAL AND NUTRACEUTICAL MUSHROOM AND CANNABIS COMPOSITIONS AND THEIR USE TO TREAT CNS DISORDERS AND IMPROVE MENTAL HEALTH”.

Lunit, a leading startup in AI-based cancer solutions, announced today the publication of its study in the Journal of Clinical Oncology (JCO). Findings from the study validate the effectiveness of Lunit’s AI biomarker, Lunit SCOPE IO, in predicting clinical outcomes of immunotherapy in patients with advanced non-small cell lung cancer (NSCLC).

BioSig Technologies, Inc., a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, announced the appointment of John Sieckhaus as Chief Operating Officer.